PRF Technologies (PRFX) Preferred Stock Liabilities (2019)
PRF Technologies (PRFX) recorded quarterly Preferred Stock Liabilities of $6.6 million in Q4 2019.
PRF Technologies (PRFX) Preferred Stock Liabilities (2019) Analysis & Trends
PRF Technologies has disclosed Preferred Stock Liabilities across 1 years of filings, most recently posting $6.6 million for Q4 2019.
- Quarterly Preferred Stock Liabilities changed N/A year-over-year to $6.6 million in Q4 2019, while the trailing twelve-month figure through Dec 2019 was $6.6 million (changed N/A YoY) and the FY2019 annual result came in at $6.6 million, changed N/A from the prior year.
- Preferred Stock Liabilities held at $6.6 million in Q4 2019.
- Over five years, Preferred Stock Liabilities peaked at $6.6 million in Q4 2019 and troughed at $6.6 million in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | PRF Technologies | 933,081.16 | -2.46 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 6.62 Mn |